Yasheng Zhu - Concepedia

Author

Yasheng Zhu

State Key Laboratory of Natural Medicine ORCID

Also Known As

Kai Yuan, L. Lai, Y. Zhu, Yasheng Zhu

Publications

677

Citations

H-Index

Concepts

All Affiliations

State Key Laboratory of Natural Medicine China Pharmaceutical University Shandong University Xuzhou Medical College Second Military Medical University

About

Yasheng Zhu is an author at State Key Laboratory of Natural Medicine specializing in medicine, drug discovery, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	288
2	Natural Sciences	3	3	52
3	Biochemistry	2	2	41
4	Engineering	1	1	11
5	Chemical Biology	1	1	11

Yasheng Zhu

Publications

567

Citations

H-Index

Page 1

	Year	Citations
Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression Shancheng Ren, Gong‐Hong Wei, Dongbing Liu, European Urology BioinformaticsUrologySomatic VariantTumor HeterogeneityMedicine	2017	193
Synthesis of Chiral Triarylmethanes Bearing All‐Carbon Quaternary Stereocenters: Catalytic Asymmetric Oxidative Cross‐Coupling of 2,2‐Diarylacetonitriles and (Hetero)arenes Zehua Wang, Yasheng Zhu, Xiaoguang Pan, Angewandte Chemie International Edition	2020	60
Cross-dehydrogenative coupling enables enantioselective access to CF<sub>3</sub>-substituted all-carbon quaternary stereocenters Xiaoguang Pan, Zehua Wang, Linglong Kan, Chemical Science	2020	47
Clinical utility of a novel urine-based gene fusion TTTY15-USP9Y in predicting prostate biopsy outcome Yasheng Zhu, Shancheng Ren, Taile Jing, Urologic Oncology Seminars and Original Investigations UrologyProstate Biopsy OutcomeGenitourinary CancerClinical UtilityGenetics	2015	37
Sensitivity to NNKOAc is associated with renal cancer risk Jessica Clague, Lina Shao, Jun Lin, Carcinogenesis	2009	37
Discovery of Potent and Wild-Type-Sparing Fourth-Generation EGFR Inhibitors for Treatment of Osimertinib-Resistance NSCLC Haojie Dong, Xiuquan Ye, Yasheng Zhu, Journal of Medicinal Chemistry	2023	32
Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs Jian Gao, Liang Li, Yasheng Zhu, International Journal of Molecular Sciences Drug TargetBioorganic ChemistryDrug ResistanceMedicinal ChemistryStructure-based Approaches	2016	30
Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting C797S Mutation Yasheng Zhu, Xiuquan Ye, Yuxing Wu, Journal of Medicinal Chemistry	2024	28
Discovery of Novel Fourth-Generation EGFR Inhibitors to Overcome C797S-Mediated Resistance Yasheng Zhu, Xiuquan Ye, Hao Shen, Journal of Medicinal Chemistry	2023	23
Discovery of novel and orally bioavailable CDK 4/6 inhibitors with high kinome selectivity, low toxicity and long-acting stability for the treatment of multiple myeloma Kai Yuan, Wenbin Kuang, Weijiao Chen, European Journal of Medicinal Chemistry Hematological MalignancyMedicinal ChemistryHigh Kinome SelectivityBioavailable Cdk 4/6Medicine	2021	17

Page 1